Related Experiment Video
Updated: Apr 17, 2026
Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
Short-term outcomes of adjustable single-incision sling (Ajust™) procedure for stress urinary incontinence: a
Tao Jiang1, Zhijun Xia1, Dali Cheng1
1Gynecology Pelvic Floor Disease Unit, Department of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, Female Pelvic Floor Diseases Diagnosis and Treatment Center in Liaoning Province, Shenyang, Liaoning Province, China.
Objectives:
Slings have become the most widely performed surgical procedure for stress urinary incontinence (SUI) in last two decades. As the third generation sling, the efficacy of the early single-incision mini-sling was controversial. The aim of this study was to determine whether the new adjustable single-incision sling (Ajust™) is safe and effective in management of female SUI at 6-18 months follow-up.
Study Design:
69 patients with SUI according the inclusion and exclusion criteria were considered adjustable single-incision sling (Ajust™) from September 2012 to September 2013. 67 patients finished 6-18 months follow-up. The data about clinical parameter, operation, complication, Urogenital Distress Inventory-Short Form (UDI-6), Incontinence Impact Questionnaire-Short Form (IIQ-7) and International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) in Chinese were collected in preoperative, 6-month and 12-month follow-up.
Results:
All patients underwent successful adjustable single-incision sling (Ajust(TM)) placement. The subjective cure rate and objective cure rate was 82.0%, 92.5% in 6-month follow-up and 82.3%, 91.2% in 12-month follow-up respectively. There were no significant perioperative complications such as bladder perforation, major bleeding requiring blood transfusion in the present study. Sling exposure was observed in two patients (3.2%).
Conclusions:
Adjustable single-incision sling (Ajust(TM)) was a safe and effective option for treating female SUI and was associated with comparable subjective and objective success rates when compared to standard midurethral slings (TVT-O) at a 6-18 months follow-up.
